Primary extremity sarcoma: What is the appropriate follow-up?

Annals of Surgical Oncology

Volumn 7, Issue 1, 2000, Pages 9-14

  Whooley, Brian P ^a   Gibbs, John F ^a   Mooney, Margaret M ^a   McGrath, Brian E ^a   Kraybill, William G ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Follow up; Recurrence; Soft tissue sarcoma

Indexed keywords

ANAMNESIS; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SOFT TISSUE SARCOMA; THORAX RADIOGRAPHY;

EID: 0033974305     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0009-x     Document Type: Article

References (32)

1. Landis SH, Murray T, Bolder S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998;48:10-11.
2. Lawrence W Jr, Donegan WL, Natarajan W, et al. Adult soft tissue sarcomas: a pattern of care survey of the American College of Surgeons. Ann Surg 1987;25:349-59.
3. Keohan ML, Taub RN. Chemotherapy for advanced sarcomas: therapeutic decisions and modalities. Semin Oncol 1997;24:572-9.
4. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
5. Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993;218: 705-12.
6. Casson AG, Putnam JB, Natarajan G, et al. Five year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992;69:662-9.
7. Van Geet AN, Pastorini U, Jauch KW, et al. The surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study of 255 patients. Cancer 1996;77:675-82.
8. NCCN sarcoma practice guidelines. Oncology 1998;3:183-218.
9. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with melanoma. JAMA 1995;272:1703-5.
10. Mooney MM, Mettlin C, Michalek AM, Petrelli NJ, Kraybill WG. Life-long screening of patients with intermediate thickness cutaneous melanoma for asymptomatic pulmonary recurrences. Cancer 1997;80:1052-64.
11. The GIVO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA 1994;271:1587-92.
12. Del Turco MR, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. JAMA 1994;271:1593-7.
13. Brennan MF. The enigma of local recurrence. Ann Surg Oncol 1997;4:1-12.
14. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
15. Singer S, Antman K, Corson JM, Eberlein TJ. Long-term salvage-ability for patients with locally recurrent soft tissue sarcomas. Arch Surg 1992;127:548-53.
16. Putnam JB Jr, Suell DM, Natarajan G, Roth JA. Extended resection of pulmonary metastases: is the risk justified? Ann Thorac Surg 1993;55:1440-6.
17. Sarcoma Meta-Analysis Collaboration. Adjuvant chemotherapy for localized resectable soft tissue sarcoma of adults: meta-analysis of individual data. Lancet 197;350:1647-54.
18. Antman K, Crowley J, Balcerzak SP, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-85.
19. Weekes RG, Berquist TH, McLeod RA, Zimmer WD. Magnetic resonance imaging of soft tissue tumors: comparison with computed tomography. Magn Reson Imaging 1985;3:345-52.
20. Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography. Skeletal Radiol 1990;19:85-90.
21. Hudson TM, Schakel M, Springfield DS. Limitations of computed tomography following excisional biopsy of soft tissue sarcomas. Skeletal Radiol 1985;13:49-54.
22. Kole AC, Nieweg OE, van Ginkel RJ, et al. Detection of local recurrence of soft tissue sarcoma with positron emission tomography using (18F) fluorodeoxyglucose. Ann Surg Oncol 1997;4:57-63.
23. Kollins SA. Computed tomography of the pulmonary parenchyma and chest wall. Radiol Clin North Am 1997;15:297-308.
24. Muhm JR, Brown LR, Crowe JK. Use of computed tomography in the detection of pulmonary nodules. Mayo Clin Proc 1977;52: 345-8.
25. Muhm JR, Brown LR, Crowe JK. Detection of pulmonary nodules by computed tomography. AJR Am J Roentgenol 1977;128:267-70.
26. Chang AE, Schaner EG, Conkle DM, Flye MW, Doppman JL, Rosenberg SA. Evaluation of computed tomography in the detection of pulmonary metastases: a prospective study. Cancer 1979; 43:913-6.
27. Schaner EG, Chang AE, Doppman JL, Conkle DM, Flye MW, Rosenberg SA. Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective-pathologic study. AJR Am J Roentgenol 1978;131:51-4.
28. Povoski SP, Fong Y, Sgouros SC, Kemeny NE, Downey RJ, Blumgart LH. Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol 1998;5:9-15.
29. Mooney MM, Whooley BP, Gibbs JF, McGrath B, Kraybill WG. The cost-effectiveness of CXR surveillance for high-grade soft tissue extremity sarcoma [Abstract]. Proc Am Soc Clin Oncol 1999;18:427a.
30. Danese ND, Powe NR, Swain CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination. JAMA 1996;276:285-92.
31. Frame PS, Frybach DG, Paterson C. Screening for abdominal aortic aneurysm in men ages 60-80. Ann Intern Med 1993;119: 411-6.
32. Littenberg B, Garber AM, Sox HC. Screening for hypertension. Ann Intern Med 1990;112:192-202.